Company intelligence / Profile preview

Bionaturis

Jerez de la Frontera, Andalusia, Spainmarketscreener.com ↗
Ownership
Private
Employees
~49
Development stage
Preclinical
01

Overview

Bionaturis develops biotechnological solutions primarily for animal health—including vaccines, feed additives, probiotics—and has expanded its portfolio through acquisitions such as ZIP Solutions. Its proprietary platforms facilitate the production/purification of complex proteins. The company merged with ADL Biopharma to form a larger entity focused on both human and animal biotech markets. It operates globally as part of the Biat Group.

Therapeutic areas
Other
Modalities
Biological vaccinesFeed additivesProbioticsRecombinant proteinsPeptidesNon-biological supplements and therapeutics for animals
Industry
Biotech
02

Drug pipeline

3 assets

bentoglucerasa

Pre-clinical
Indications
Gaucher disease type I

2 more assets in the full pipeline.

Request access →
03

Partnerships

Co-development/license agreement with a leading multinational company for Splittera® technology; details undisclosed.

Beyond the preview

Go deeper on Bionaturis.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bionaturis.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call